n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with mobiflex in 1 studies
Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (mobiflex) | Trials (mobiflex) | Recent Studies (post-2010) (mobiflex) |
---|---|---|---|---|---|
98 | 0 | 29 | 519 | 207 | 87 |
Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | mobiflex (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Itoga, H; Kohno, Y; Nagata, K; Yamamoto, T; Yamazoe, Y | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and mobiflex
Article | Year |
---|---|
Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models.
Topics: Administration, Oral; Animals; Anisoles; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 Enzyme System; Dogs; Humans; Male; Metabolic Clearance Rate; Metoprolol; Models, Biological; Piroxicam; Predictive Value of Tests; Propylamines; Rats; Rats, Wistar; Recombinant Proteins | 2005 |